BlackRock Group’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$176M Sell
2,201,625
-367,576
-14% -$29.2M 0.08% 280
2016
Q3
$205M Sell
2,569,201
-260,109
-9% -$21M 0.1% 235
2016
Q2
$221M Sell
2,829,310
-553,661
-16% -$39.5M 0.11% 210
2016
Q1
$186M Buy
3,382,971
+179,862
+6% +$9.8M 0.1% 240
2015
Q4
$198M Buy
3,203,109
+32,383
+1% +$2.04M 0.11% 215
2015
Q3
$200M Buy
3,170,726
+234,421
+8% +$16.7M 0.12% 198
2015
Q2
$215M Buy
2,936,305
+94,532
+3% +$6.83M 0.12% 202
2015
Q1
$186M Sell
2,841,773
-40,065
-1% -$2.66M 0.1% 241
2014
Q4
$187M Buy
2,881,838
+144,577
+5% +$9.31M 0.1% 238
2014
Q3
$165M Sell
2,737,261
-37,321
-1% -$2.44M 0.1% 246
2014
Q2
$192M Sell
2,774,582
-245,709
-8% -$15.9M 0.11% 221
2014
Q1
$197M Buy
3,020,291
+460,434
+18% +$30M 0.12% 190
2013
Q4
$159M Buy
2,559,857
+124,774
+5% +$7.23M 0.1% 227
2013
Q3
$131M Buy
2,435,083
+76,042
+3% +$3.92M 0.09% 259
2013
Q2
$108M Buy
+2,359,041
New +$102M 0.08% 280

Other funds holding STJ

BlackRock Group's STJ Position: Q4 2016 in Review

BlackRock Group reduced its St Jude Medical (STJ) stake by 14% in Q4 2016, selling an estimated $29.2M and leaving 2,201,625 shares worth $176M. The position accounts for 0.08% of the portfolio, ranked #280.

BlackRock Group first reported a position in STJ in Q2 2013 and has held it in 15 quarters since. The position peaked at $221M in Q2 2016. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

  • BlackRock Group held 2,201,625 shares of St Jude Medical worth $176M as of Q4 2016.
  • BlackRock Group sold 367,576 St Jude Medical shares in Q4 2016, an estimated $29.2M.
  • St Jude Medical made up 0.08% of BlackRock Group's portfolio in Q4 2016, its #280 holding.
  • BlackRock Group first reported a position in St Jude Medical in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's St Jude Medical position peaked at $221M in Q2 2016.
  • 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.